RT Journal Article
SR Electronic
T1 Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: a modelling analysis based on overseas cases and air travel data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.02.20030320
DO 10.1101/2020.03.02.20030320
A1 Zhuang, Zian
A1 Zhao, Shi
A1 Lin, Qianying
A1 Cao, Peihua
A1 Lou, Yijun
A1 Yang, Lin
A1 He, Daihai
YR 2020
UL http://medrxiv.org/content/early/2020/03/06/2020.03.02.20030320.abstract
AB As of 1 March 2020, Iran has reported 987 COVID-19 cases and including 54 associated deaths. At least six neighboring countries (Bahrain, Iraq, Kuwait, Oman, Afghanistan and Pakistan) have reported imported COVID-19 cases from Iran. We used air travel data and the cases from Iran to other Middle East countries and estimated 16533 (95% CI: 5925, 35538) COVID-19 cases in Iran by 25 February, before UAE and other Gulf Cooperation Council countries suspended inbound and outbound flights from Iran.Competing Interest StatementDH was supported by an Alibaba (China) - Hong Kong Polytechnic University Collaborative Research project. Other authors declare no competing interests. Funding StatementDH was supported by General Research Fund (15205119) of Research Grants Council of Hong Kong and an Alibaba-Hong Kong Polytechnic University Collaborative Research project. The funding agencies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe used only publicly available data.